Celularity Inc. - Class A Common Stock (CELU)

0.7803
+0.0122 (1.59%)
NASDAQ· Last Trade: Jul 18th, 8:08 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.7681
Open0.7600
Bid0.7603
Ask0.7742
Day's Range0.7500 - 0.8436
52 Week Range0.5601 - 4.350
Volume16,925
Market Cap22.11M
PE Ratio (TTM)-0.2343
EPS (TTM)-3.3
Dividend & YieldN/A (N/A)
1 Month Average Volume130,113

Chart

About Celularity Inc. - Class A Common Stock (CELU)

Celularity Inc is a biotechnology company focused on developing innovative cell therapies and regenerative medicine solutions. The company harnesses the power of placental-derived cells and utilizes cutting-edge technology to create treatments aimed at addressing various health challenges, including cancer, autoimmune diseases, and age-related conditions. Celularity is committed to advancing the science of cell therapy and aims to improve patient outcomes through its unique approach to harnessing the immune system and addressing unmet medical needs. Through ongoing research and development, the company seeks to unlock the potential of cellular therapeutics and contribute to the future of medicine. Read More

News & Press Releases

Which stocks are experiencing notable movement on Monday?chartmill.com
Via Chartmill · July 6, 2026
Keep an eye on the top gainers and losers in Monday's session.chartmill.com
Via Chartmill · July 6, 2026
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
FLORHAM PARK, N.J. and ORLANDO, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company pioneering placental-derived cellular therapies, and Fountain Life Management, LLC (“Fountain Life”), a leading healthy longevity company delivering a next-generation preventive health model through advanced diagnostics, restorative therapeutics, and AI-driven health intelligence, today announced the availability of cenplacel-L, a placental-derived allogeneic investigational cell therapy, for investigational use by licensed physicians in the State of Florida under recently enacted legislation supporting responsible use of regenerative medicine.
By Celularity Inc. · Via GlobeNewswire · June 4, 2026
Curious about the stocks that are showing activity after the closing bell on Friday?chartmill.com
Via Chartmill · May 1, 2026
These stocks have an unusual volume in today's sessionchartmill.com
Via Chartmill · March 11, 2026
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · October 14, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Via Benzinga · September 29, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 9, 2025
Here are the top movers in Tuesday's session.chartmill.com
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · September 2, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · September 2, 2025
Dow Tumbles Over 1%; Nio Shares Edge Lower After Q2 Resultsbenzinga.com
Via Benzinga · September 2, 2025
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.chartmill.com
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · September 2, 2025
There are notable gap-ups and gap-downs in today's session.chartmill.com
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · September 2, 2025
Nasdaq Down 1%; Signet Jewelers Earnings Top Viewsbenzinga.com
Via Benzinga · September 2, 2025
Tuesday's pre-market session: top gainers and loserschartmill.com
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · September 2, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 2, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 28, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · July 22, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · July 22, 2025
Unusual volume stocks in Tuesday's sessionchartmill.com
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via Chartmill · July 22, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · July 16, 2025
Get insights into the top gainers and losers of Wednesday's pre-market session.chartmill.com
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · July 16, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 16, 2025
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · July 16, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · July 15, 2025